GS-1160-180
GS-1160-180 is a PAF receptor antagonist. GS-1160-180 competes with PAF for receptor binding, with no activity against collagen or adenosine diphosphate-induced platelet aggregation. GS-1160-180 can be used for research on asthma, anaphylactic shock, gastric ulceration, and transplant rejection.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 111878-47-8
- Formel: C33H59BrN2O4S
- Molecular Weight:659.80
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
GS-1160-180 (Compound 10) (100 nM; 3 min) competitively and specifically inhibits PAF-induced platelet aggregation in rabbit platelet-rich plasma, and shows no aggregation-inducing activity or off-target inhibition at concentrations ≤100 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
GS-1160-180 (0.5 mg/kg; i.v.; single dose) inhibits PAF-induced hypotension in rats, with an ED50 of 0.5 mg/kg i.v[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 111878-47-8
-
Molecular Weight 659.80
-
Formel C33H59BrN2O4S
-
SMILES
O=C(NCCCCCCCCCCCCCCCCCC)OCC(COC(CCCCCC[N+]1=CSC=C1)=O)=C.[Br-]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)